Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): an ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial - Socinski, M A; Wang, X F; Baggstrom, M Q (J Clin Oncol, 2014)
, et al.